-
Landmark Long-Term Follow-Up Results Published: Headlines on CNN, New York Times, Military.com, etc.
-
U.S. Proof of Principle Study: Long-Term Follow-Up Paper Accepted for Publication
-
U.S. Proof of Principle Study: Revised Long-Term Follow-Up Paper Submitted to Scientific Journal
-
U.S. Proof of Principle Study: Reviewers Respond to Long-Term Follow-Up Paper
-
U.S. Proof of Principle Study: Results of Long-Term Follow-Up Submitted to Scientific Journal
-
Ethics Board Approves US MDMA/PTSD Relapse Study Protocol
-
FDA Approves New MDMA/PTSD Relapse Study
-
Annual MDMA Report Submitted to the FDA
-
Mithoefer Presents Second Poster at ISTSS
-
Database for U.S. MDMA/PTSD Long-Term Follow-Up Study Finalized
-
Preparation of Final Report to FDA on Initial MDMA/PTSD Study
-
Paper in Progress About Long-Term Follow-up to First U.S. MDMA/PTSD Study
-
Long-term Follow-up of U.S. MDMA/PTSD Pilot Study is Complete
-
Journal of Psychopharmacology Publishes Paper About MAPS-sponsored U.S. MDMA/PTSD Pilot Study
-
U.S. MDMA/PTSD Paper Revised and Resubmitted; Long-Term Follow-Up Study Continues
-
Second MDMA/PTSD Therapist Training Program, Soliciting More Applicants
-
MAPS Clinical Plan for End-of-Phase 2 Meeting with the U.S. FDA to Develop MDMA as a Prescription Medicine for PTSD
-
MAPS US MDMA/PTSD researchers, including Michael Mithoefer
-
Flagship US MDMA/PTSD Study Final Monitoring Visit
-
Canadian IRB Gives Conditional Approval To MDMA/PTSD Protocol